Biological aortic valves do not last indefinitely!
Media release from Helios Kliniken:
Biological aortic valves do not last indefinitely. If further intervention becomes necessary, the treatment decision requires a sound basis. This is precisely what the international REPEAT study is working on. This year's World Health Day focuses on strengthening science as the foundation for better health. This is also the aim of this study.
Helios participates in this through the Helios Health Institute. There, Helios consolidates clinical studies and health research. The institute supports research projects and works with healthcare data from everyday clinical practice to make medical findings applicable to patient care.
This is relevant for cardiology because the study addresses a specific question in patient care that has not yet been answered by a direct randomized controlled trial with long-term follow-up. The REPEAT trial aims to contribute to a more reliable data basis for future decisions regarding repeat interventions on biological aortic valves.
Prof. Dr. med. Michael A. Borger, PhD, Medical Director, Director of the University Clinic for Cardiac Surgery & Professor of Cardiac Surgery at the University of Leipzig, says:
"Our international collaboration shows how research can work across borders – and how we can jointly develop therapies that bring real long-term benefits to our patients"
for more: helios-gesundheit.de
Photo: ©Helios
“All rights belong to Helios Kliniken GmbH” (for this news)